Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boiron, P.
Right arrow Articles by Provost, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boiron, P.
Right arrow Articles by Provost, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1988) 22, 623-629
© 1988 The British Society for Antimicrobial Chemotherapy

research-article

In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication

Patrick Boiron and Frédérique Provost

Institut Pasteur—Unité de Mycologie 28, rue du Dr Roux, 75724 Paris Cedex 15, France

Received 12 February 1988; returned 11 July 1988; accepted 11 July 1988

By disc diffusion, 28 clinical isolates of four species of Nocardia were tested against 16 antimicrobial agents. Among the drugs included in the study, only a few exhibited in-vitro activities. A species difference in susceptibility was noted for amoxicillin ± clavulanic acid, kanamycin, gentamicin, chloramphenicol, minocycline and erythromycin, which was of clinical and taxonomic interest. All six N. brasiliensis and six N. otitidis-caviarum were susceptible to gentamicin and niinocycline, while all 15 N. asteroides were not. In addition, N. otitidis-caviarum was susceptible to kanamycin and chloramphenicol, while the sensitivity of N. farcinica was less predictable. The only antibiotic to which members of all of the Nocardia species tested were susceptible was amikacin, which therefore appears to be a good candidate for the treatment of all forms of nocardial infections.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Microbiol.Home page
M. Eisenblatter, U. Disko, G. Stoltenburg-Didinger, H. Scherubl, K. P. Schaal, A. Roth, R. Ignatius, M. Zeitz, H. Hahn, and J. Wagner
Isolation of Nocardia paucivorans from the Cerebrospinal Fluid of a Patient with Relapse of Cerebral Nocardiosis
J. Clin. Microbiol., September 1, 2002; 40(9): 3532 - 3534.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. Sharma, M. S. Sridhar;, and U. M. Tendolkar
Diagnosis and Management of Nocardia Keratitis
J. Clin. Microbiol., July 1, 1999; 37(7): 2389 - 2389.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.